... biotechnology companies evaluating U.S.-based production. Its San Antonio facility supports GMP microbial drug-substance manufacturing at scales ...
News
- Valion Bio highlights U.S. clinical drug manufacturing | VBIO 8-K Filing - Stock Titan
- Jaguar Promise Expands Access to Higher Education at A&M-San Antonio - PR Newswire
PRNewswire/ -- As Texas A&M University-San Antonio's enrollment reached 7697 students in Fall 2026, including a record 1322 first-time-in-college ...
- With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on ...
SAN ANTONIO, TX / ACCESS Newswire / October 14, 2026 / Valion Bio, Inc. (NASDAQ: VBIO) ("Valion" or the "Company"), a clinical-stage ...
- UT San Antonio study finds endometrial cancer rates highest in San Antonio region
UT San Antonio study finds endometrial cancer rates highest in San Antonio region ... biomedical sciences and public health that are leading ...
- With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on ...
Velocity Bioworks' San Antonio facility offers process development, analytical services, and early-phase clinical drug substance manufacturing for ...